Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
We are pleased to announce that Sabin executive vice president, Ciro de Quadros, M.D., M.P.H., has been awarded the BBVA Frontiers of Knowledge Award in Development Cooperation, an international distinction of the highest level. Dr.
Recent news reports about Brazil indicate rising concerns about the prevalence of dengue in the country. In mid-February, Brazil’s health minister Alexandre Padilha warned of an impending dengue epidemic due to the discovery of a new type of dengue virus (type 4) in the populous city of Rio de Janeiro.
A recent expert meeting on typhoid epidemiological modeling, organized by the Coalition against Typhoid, marks one of the first attempts to jolt governments into action against typhoid fever, a disease that is thriving largely unnoticed in many developing countries.